| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Revenue | $92.7M | +14.5% |
| Cost of Revenue | $40.0M | +16.9% |
| Gross Profit | $52.7M | +12.7% |
| R&D Expense | $12.1M | +21.1% |
| SG&A Expense | $20.6M | +30.5% |
| Operating Income | -$1.2M | -116.0% |
| Pre-tax Income | -$1.5M | -120.0% |
| Income Tax | $1.2M | +3.2% |
| Net Income | -$2.7M |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $5.7M | -45.6% |
| Accounts Receivable | $24.6M | -14.6% |
| Current Assets | $40.3M | -9.8% |
| Total Assets | $138.7M | +13.0% |
| Current Liabilities | $59.8M | +11.8% |
| Total Liabilities | $64.0M | +3.5% |
| Stockholders' Equity | $74.8M | +22.7% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $11.0M | -10.1% |
| Capital Expenditures | $5.1M | -53.7% |
| Investing Cash Flow | -$16.5M | -6.1% |
| Financing Cash Flow | $795K | +145.5% |
| Free Cash Flow | $5.9M | +364.8% |
| -142.6% |
| EPS (Basic) | -$0.22 | -142.3% |
| EPS (Diluted) | -$0.22 | -142.3% |